These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 23127262)
1. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment. Okuyaz C; Kursel O; Komur M; Tamer L Pediatr Neurol; 2012 Dec; 47(6):423-6. PubMed ID: 23127262 [TBL] [Abstract][Full Text] [Related]
2. The effect of topiramate on body weight and ghrelin, leptin, and neuropeptide-Y levels of prepubertal children with epilepsy. Ozcelik AA; Serdaroglu A; Bideci A; Arhan E; Soysal Ş; Demir E; Gücüyener K Pediatr Neurol; 2014 Aug; 51(2):220-4. PubMed ID: 25079570 [TBL] [Abstract][Full Text] [Related]
3. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy. Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963 [TBL] [Abstract][Full Text] [Related]
4. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children. Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A Seizure; 2018 May; 58():90-95. PubMed ID: 29679911 [TBL] [Abstract][Full Text] [Related]
5. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine. Cansu A; Serdaroglu A; Cinaz P Eur J Paediatr Neurol; 2011 Nov; 15(6):527-31. PubMed ID: 21703891 [TBL] [Abstract][Full Text] [Related]
6. Effects of topiramate on weight and metabolism in children with epilepsy. Li HF; Zou Y; Xia ZZ; Gao F; Feng JH; Yang CW Acta Paediatr; 2009 Sep; 98(9):1521-5. PubMed ID: 19508301 [TBL] [Abstract][Full Text] [Related]
7. Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate. Tokgoz H; Aydin K; Oran B; Kiyici A Childs Nerv Syst; 2012 Jul; 28(7):1049-53. PubMed ID: 22645062 [TBL] [Abstract][Full Text] [Related]
8. Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment. Genc BO; Dogan EA; Dogan U; Genc E J Clin Neurosci; 2010 Oct; 17(10):1256-9. PubMed ID: 20598547 [TBL] [Abstract][Full Text] [Related]
9. Changes in growth pattern, leptin ghrelin and neuropeptide Y levels after adenotonsillectomy in prepubertal children. Andiran N; Celik N; Ark N; Koca C; Kurtaran H; Karabel D J Pediatr Endocrinol Metab; 2013; 26(7-8):683-7. PubMed ID: 23612639 [TBL] [Abstract][Full Text] [Related]
10. Predictors of weight loss in adults with topiramate-treated epilepsy. Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085 [TBL] [Abstract][Full Text] [Related]
11. A prospective study of body weight and serum leptin levels in patients treated with topiramate. Theisen FM; Beyenburg S; Gebhardt S; Kluge M; Blum WF; Remschmidt H; Elger CE; Hebebrand J Clin Neuropharmacol; 2008; 31(4):226-30. PubMed ID: 18670246 [TBL] [Abstract][Full Text] [Related]
12. The role of ghrelin in weight gain and growth in epileptic children using valproate. Gungor S; Yücel G; Akinci A; Tabel Y; Ozerol IH; Yologlu S J Child Neurol; 2007 Dec; 22(12):1384-8. PubMed ID: 18174556 [TBL] [Abstract][Full Text] [Related]
13. Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving valproate. Cansu A; Serdaroglu A; Camurdan O; Hırfanoğlu T; Cinaz P Horm Res Paediatr; 2011; 76(1):65-71. PubMed ID: 21659721 [TBL] [Abstract][Full Text] [Related]
14. Weight reducing and metabolic effects of topiramate in patients with migraine--an observational study. Schütt M; Brinkhoff J; Drenckhan M; Lehnert H; Sommer C Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):449-52. PubMed ID: 20200812 [TBL] [Abstract][Full Text] [Related]
15. Serum insulin, leptin, and neuropeptide y levels in epileptic children treated with valproate. Aydin K; Serdaroglu A; Okuyaz C; Bideci A; Gucuyener K J Child Neurol; 2005 Oct; 20(10):848-51. PubMed ID: 16417885 [TBL] [Abstract][Full Text] [Related]
16. [Changes of body weight and galanin in epileptic children treated with topiramate]. Shi RF; Wang KL; Li QH; Zheng HC; Yang HF; Tang HX; Sun SZ; Wang LH; Tian J Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):199-202. PubMed ID: 17504624 [TBL] [Abstract][Full Text] [Related]
17. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats. Kobeissy FH; Jeung JA; Warren MW; Geier JE; Gold MS Addict Biol; 2008 Mar; 13(1):15-25. PubMed ID: 17910739 [TBL] [Abstract][Full Text] [Related]
18. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects. Husum H; Van Kammen D; Termeer E; Bolwig G; Mathé A Neuropsychopharmacology; 2003 Jul; 28(7):1292-9. PubMed ID: 12700690 [TBL] [Abstract][Full Text] [Related]
19. [Relationships between serum ghrelin and lipid profile and serum leptin, adiponectin, and insulin among children in Beijing, China]. Du S; Hu X; Liu A; Zhang Q; Pan H; Ma G Wei Sheng Yan Jiu; 2013 Mar; 42(2):252-6, 262. PubMed ID: 23654102 [TBL] [Abstract][Full Text] [Related]
20. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity. Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]